TearLab
TearLab Corporation is a privately-owned, established company that pioneers the future of tear film diagnostics to elevate patient care. It is committed to expanding its portfolio of products and services, in turn allowing practices to offer a comprehensive DED service to patients. The osmolarity test is regarded as an “Essential” test by key industry societies, and empowers a clinician to accurately and effectively diagnose DED. It has been cited in over 100 reviewed publications, and has been rapidly adopted by practices as a vital part of routine ocular surface assessment.
